tradingkey.logo

Hinge Health Inc

HNGE
查看详细走势图
31.170USD
-0.620-1.95%
收盘 02/06, 16:00美东报价延迟15分钟
2.45B总市值
亏损市盈率 TTM

Hinge Health Inc

31.170
-0.620-1.95%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.95%

5天

-10.69%

1月

-36.92%

6月

-45.01%

今年开始到现在

-32.90%

1年

0.00%

查看详细走势图

TradingKey Hinge Health Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Hinge Health Inc当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗服务供应商行业排名28/75位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价62.62。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Hinge Health Inc评分

相关信息

行业排名
28 / 75
全市场排名
152 / 4521
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Hinge Health Inc亮点

亮点风险
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
估值高估
公司最新PE估值-3.27,处于3年历史高位
乔治·索罗斯持仓
明星投资者乔治·索罗斯持仓,最新持仓市值78.56K

分析师目标

根据 17 位分析师
买入
评级
62.625
目标均价
+100.91%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Hinge Health Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Hinge Health Inc简介

Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
公司代码HNGE
公司Hinge Health Inc
CEOPerez (Daniel Antonio)
网址https://en-gb.hingehealth.com/
KeyAI